Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: US FDA Approves Koselugo, Bestows BTDs On Bavencio, Sotatercept

Apr 14 2020

• By Bridget Silverman

Keeping Track Feature image

Related Content

Keeping Track Of User Fee Decisions And Filings: Adakveo, Brukinsa And Fetroja Mark Massive Week Of Novel Approvals

Nov 17 2019

Array's Three Value Drivers Align With Pfizer's Three Oncology Pillars In $11.4bn Deal

Jun 18 2019

Alnylam Seeking Lumasiran Approvals Soon, But Has Two Rivals On Its Heels

Dec 18 2019

Acceleron Buoyed By Sotatercept’s Promise In PAH

Jan 28 2020

Related Companies

Genentech, Inc.

AstraZeneca PLC

Merck & Co., Inc.

Pfizer Inc.

Array BioPharma, Inc.

Alnylam Pharmaceuticals Inc.

Merck KGaA

Acceleron Pharma, Inc.

Additional Topics

United States Approvals Drug Review Regulation Review Pathway US FDA Performance Tracker BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window